On October 5, 2020 BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) reported to publish the company’s Interim Report for the period January – September 2020 on Wednesday, October 14, 2020, at 08:00 a.m. CET (Press release, BioArctic Neuroscience, OCT 5, 2020, View Source;september-2020-on-october-14-at-9-30-am-cet-301146256.html [SID1234568120]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BioArctic invites to an audiocast with teleconference (in English) for investors, analysts and media on October 14, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the Interim Report for the period January – September 2020 followed by a Q&A-session.

Webcast: View Source

The webcast will afterwards also be available on demand at BioArctic’s corporate website View Source